# Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors

> **NCT04377360** · NA · COMPLETED · sponsor: **Alpha Tau Medical LTD.** · enrollment: 10 (actual)

## Conditions studied

- Malignant Skin Tumor
- Soft Tissue Tumor, Malignant

## Interventions

- **RADIATION:** Diffusing Alpha-emitter Radiation Therapy

## Key facts

- **NCT ID:** NCT04377360
- **Lead sponsor:** Alpha Tau Medical LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-06
- **Primary completion:** 2022-03-28
- **Final completion:** 2022-03-28
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04377360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04377360, "Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04377360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*